New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples

Autor: Dovile Stravinskiene, Vilma Petrikaite, Daumantas Matulis, Aiste Imbrasaite, Jurgita Matuliene, Aurelija Zvirbliene
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Protein Denaturation
medicine.drug_class
cancer biomarkers
lcsh:QR1-502
Biomarkers
tumor

Carbonic anhydrase IX
Antigens
neoplasm

Immunoassay
Antibodies
monoclonal

Monoclonal antibody
udc:616-006.6
Biochemistry
Article
lcsh:Microbiology
Flow cytometry
03 medical and health sciences
Epitopes
0302 clinical medicine
Western blot
Antigen
Antigens
Neoplasm

Cell Line
Tumor

Neoplasms
medicine
Biomarkers
Tumor

Humans
Carbonic Anhydrase IX
Molecular Biology
Early Detection of Cancer
Linear epitope
medicine.diagnostic_test
Chemistry
Cell Membrane
human carbonic anhydrase IX
Antibodies
Monoclonal

Molecular biology
Recombinant Proteins
immunoassays
030104 developmental biology
Cell culture
A549 Cells
030220 oncology & carcinogenesis
MCF-7 Cells
Tumor Hypoxia
monoclonal antibodies
Clone (B-cell biology)
616-006.6 [udc]
HeLa Cells
Zdroj: Biomolecules, Basel : MDPI Publishing, 2019, vol. 9, no. 8, 304, p. 1-23
Biomolecules, Vol 9, Iss 8, p 304 (2019)
Biomolecules
Volume 9
Issue 8
ISSN: 2218-273X
Popis: Monoclonal antibodies (MAbs) selectively targeting tumor-associated antigens such as carbonic anhydrase IX (CA IX) can significantly contribute to research, diagnostics, and treatment of CA IX-related cancers. CA IX is overexpressed in numerous hypoxic cancers where it promotes tumor progression. Therefore, it is considered as a promising tumor biomarker. A novel collection of MAbs against recombinant CA IX was developed and evaluated in different immunoassays for studying CA IX expression. The reactivity of MAbs with native cell surface protein was confirmed by flow cytometry and the presence of hypoxia-inducible CA IX was investigated in several human cancer cell lines. In addition, the applicability of MAbs for visualization of CA IX-positive tumor cells by immunofluorescence microscopy was demonstrated. MAb H7 was identified as the most promising MAb for different immunoassays. It recognized a linear epitope covering CA IX sequence of 12 amino acid residues 55-GEDDPLGEEDLP-66 within the proteoglycan domain. The MAb H7 was the only one of the collection to immunoprecipitate CA IX protein from cell lysates and detect the denatured CA IX with near-infrared fluorescence Western blot. It was also employed in sandwich enzyme-linked immunosorbent assay to detect a soluble form of CA IX in growth medium of tumor cells and blood plasma samples. The diagnostic potential of the MAb H7 was confirmed on formalin-fixed and paraffin-embedded tissue specimen of cervical carcinoma in situ by immunohistochemistry. The generated MAbs, in particularly clone H7, have great potential in diagnostics and research of CA IX-related cancers.
Databáze: OpenAIRE